See more : Banco do Estado do Rio Grande do Sul S.A. (BRSR6.SA) Income Statement Analysis – Financial Results
Complete financial analysis of AngioSoma, Inc. (SOAN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AngioSoma, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- CoreCard Corporation (INS) Income Statement Analysis – Financial Results
- Capital Partners S.A. (CPA.WA) Income Statement Analysis – Financial Results
- Averbuch Formica Center Ltd. (AVER.TA) Income Statement Analysis – Financial Results
- Auswide Bank Ltd (ABA.AX) Income Statement Analysis – Financial Results
- Unieuro S.p.A. (0ROF.L) Income Statement Analysis – Financial Results
AngioSoma, Inc. (SOAN)
About AngioSoma, Inc.
AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 77.00 | 425.00 | 890.00 | 0.00 | 0.00 | 42.15K | 97.25K | 57.36K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 37.68K | 154.00 | 207.00 | 0.00 | 0.00 | 17.64K | 20.21K | 6.29K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -37.61K | 271.00 | 683.00 | 0.00 | 0.00 | 24.51K | 77.04K | 51.08K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -48,837.66% | 63.76% | 76.74% | 0.00% | 0.00% | 58.15% | 79.21% | 89.04% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 266.07K | 316.14K | 351.74K | 460.91K | 155.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 266.07K | 316.14K | 351.74K | 460.91K | 155.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 3.00M | 588.43K | 532.98K | 616.13K | 944.97K | 54.11K | -2.08K |
| Operating Expenses | 266.07K | 316.14K | 351.74K | 460.91K | 3.15M | 588.43K | 532.98K | 616.13K | 944.97K | 54.11K | -2.08K |
| Cost & Expenses | 303.75K | 316.30K | 351.94K | 460.91K | 3.15M | 606.07K | 553.20K | 622.42K | 944.97K | 54.11K | 2.08K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 238.06K | 360.36K | 103.49K | 635.69K | -137.28K | 387.92K | 787.60K | 300.91K | 143.86K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.33K | 472.00 | 118.00 | -583.20K | -486.48K | 22.12K | -1.62K | 61.00K | 0.00 | 0.00 | 0.00 |
| EBITDA | -302.34K | -314.24K | -713.13K | -1.04M | -3.64M | -675.63K | -457.57K | -584.20K | -944.97K | -54.11K | -2.08K |
| EBITDA Ratio | -392,651.95% | -73,938.12% | -80,127.30% | 0.00% | 0.00% | -1,602.79% | -470.50% | -1,018.46% | 0.00% | 0.00% | 0.00% |
| Operating Income | -303.67K | -315.87K | -351.05K | -460.91K | -3.15M | -563.91K | -455.94K | -565.06K | -944.97K | -54.11K | -2.08K |
| Operating Income Ratio | -394,377.92% | -74,322.35% | -39,444.04% | 0.00% | 0.00% | -1,337.78% | -468.83% | -985.09% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -238.06K | -359.20K | -465.69K | -1.22M | -346.60K | -521.75K | -789.23K | -381.05K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -541.73K | -675.07K | -816.74K | -1.68M | -3.50M | -1.09M | -1.25M | -946.11K | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -703,546.75% | -158,840.47% | -91,768.65% | 0.00% | 0.00% | -2,575.53% | -1,280.35% | -1,649.40% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.16K | -362.20K | 0.00 | 2.60K | -133.83K | 0.00 | -80.14K | 1.09M | 54.11K | 2.08K |
| Net Income | -541.73K | -675.07K | -816.74K | -1.68M | -3.50M | -1.09M | -1.25M | -946.11K | -1.09M | -54.11K | -2.08K |
| Net Income Ratio | -703,546.75% | -158,840.47% | -91,768.65% | 0.00% | 0.00% | -2,575.53% | -1,280.35% | -1,649.40% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | -0.01 | -0.01 | -0.04 | -0.13 | -0.66 | -7.50 | -11.99 | -116.38 | -12.02 | -0.46 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.04 | -0.13 | -0.66 | -7.50 | -11.99 | -116.38 | -12.02 | -0.46 |
| Weighted Avg Shares Out | 298.09M | 56.51M | 56.51M | 38.97M | 26.65M | 1.64M | 165.92K | 78.92K | 9.36K | 4.50K | 4.50K |
| Weighted Avg Shares Out (Dil) | 298.09M | 56.51M | 56.51M | 38.97M | 26.65M | 1.64M | 165.92K | 78.92K | 9.36K | 4.50K | 4.50K |
No news found for: SOAN
Source: https://incomestatements.info
Category: Stock Reports